Literature DB >> 6325545

A simple reliable assay for myeloperoxidase activity in mixed neutrophil-eosinophil cell suspensions: application to detection of myeloperoxidase deficiency.

R Cramer, M R Soranzo, P Dri, R Menegazzi, A Pitotti, G Zabucchi, P Patriarca.   

Abstract

Quantitation of myeloperoxidase (MPO) activity by guaiacol peroxidation (GP) assay is profoundly affected by the peroxidase present in eosinophils (EPO) that contaminate the granulocyte suspensions. Inclusion of 3-amino-1,2,4-triazole (AMT) in the GP assay permits quantitation of MPO activity in mixed neutrophil-eosinophil suspension because of the differential inhibition of EPO and MPO by AMT. Results show that: (1) the peroxidase activity of eosinophil-free granulocyte suspensions is not appreciably affected by AMT; (2) in the presence of AMT the peroxidase activities of granulocyte preparations containing different numbers of eosinophils are similar on a neutrophil basis, regardless of the number of eosinophils and correspond with the activity of eosinophil-free granulocyte suspensions; (3) AMT almost completely inhibits the activity of partially purified EPO, only slightly affecting the catalytic activity of partially purified MPO; (4) AMT completely inhibits the residual peroxidase activity of granulocyte suspensions from MPO-deficient subjects contributed by contaminating eosinophils. The GP assay in the presence of AMT was used to study the pattern of hereditary transmission of MPO deficiency. The genealogy derived on the basis of this assay was compatible with an autosomal recessive inheritance, in agreement with previously reported results, while no definite pattern of inheritance could be established by use of the GP assay without AMT. We suggest that the GP assay supplemented with AMT is the method of choice for detection of MPO deficiency, particularly partial deficiency.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325545     DOI: 10.1016/0022-1759(84)90396-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Effect of in vivo desensitization to leukotriene B4 on eosinophil infiltration in response to C5a in guinea-pig skin.

Authors:  E R Pettipher; E D Salter; H J Showell
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

2.  Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor.

Authors:  A Dobrina; R Menegazzi; T M Carlos; E Nardon; R Cramer; T Zacchi; J M Harlan; P Patriarca
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Synthesis of {alpha}(1,3) fucosyltransferases IV- and VII-dependent eosinophil selectin ligand and recruitment to the skin.

Authors:  Takahiro Satoh; Yasumasa Kanai; Ming-Hua Wu; Hiroo Yokozeki; Reiji Kannagi; John B Lowe; Kiyoshi Nishioka
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

4.  Infection course of the strobilar stage of Taenia crassiceps in golden hamsters, with reference to host responses.

Authors:  H Sato; H Kamiya; Y Oku; M Kamiya
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

5.  Intercellular adhesion molecule-1 contributes to pulmonary oxygen toxicity in mice: role of leukocytes revised.

Authors:  C D Wegner; W W Wolyniec; A M LaPlante; K Marschman; K Lubbe; N Haynes; R Rothlein; L G Letts
Journal:  Lung       Date:  1992       Impact factor: 2.584

6.  Mutual influence between eosinophil peroxidase (EPO) and neutrophils: neutrophils reversibly inhibit EPO enzymatic activity and EPO increases neutrophil adhesiveness.

Authors:  G Zabucchi; R Menegazzi; R Cramer; E Nardon; P Patriarca
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

7.  Degradation of biomaterials by phagocyte-derived oxidants.

Authors:  K Sutherland; J R Mahoney; A J Coury; J W Eaton
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

8.  Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.

Authors:  C Kroegel; T Yukawa; G Dent; P Chanez; K F Chung; P J Barnes
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

9.  Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis.

Authors:  Violetta Borelli; Francesca Vita; Sandeep Shankar; Maria Rosa Soranzo; Elena Banfi; Giuditta Scialino; Cristiana Brochetta; Giuliano Zabucchi
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.